160 related articles for article (PubMed ID: 1726164)
21. Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results.
Baskin G; DiNello R; Polito A; Quan S; Lee WS; Wu J; Nelles M; Lee S
Gut; 1993; 34(2 Suppl):S61. PubMed ID: 7686119
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus infection and mixed cryoglobulinemia: a striking association.
Dammacco F; Sansonno D; Cornacchiulo V; Mennuni C; Carbone R; Lauletta G; Iacobelli AR; Rizzi R
Int J Clin Lab Res; 1993; 23(1):45-9. PubMed ID: 7682861
[TBL] [Abstract][Full Text] [Related]
24. Anti-hepatitis C virus antibodies in monoclonal gammopathy: an appraisal using the second generation tests.
Marson P; Vicarioto M; De Silvestro G; Tenderini ML; Nardo G; Ongaro G
Haematologica; 1992; 77(2):188. PubMed ID: 1328000
[No Abstract] [Full Text] [Related]
25. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C infection in BMT patients.
Kolho E; Ruutu P; Ruutu T
Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
[TBL] [Abstract][Full Text] [Related]
27. Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection.
King PD; McMurray RW; Becherer PR
Am J Gastroenterol; 1994 Jul; 89(7):1047-50. PubMed ID: 7517099
[TBL] [Abstract][Full Text] [Related]
28. Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N
Virol J; 2016 Jun; 13():116. PubMed ID: 27357382
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
30. New-generation RIBA hepatitis C strip immunoblot assays.
Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698
[TBL] [Abstract][Full Text] [Related]
31. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
Bååth L; Widell A; Nordenfelt E
J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia.
Gharagozloo S; Khoshnoodi J; Shokri F
Pathol Oncol Res; 2001; 7(2):135-9. PubMed ID: 11458277
[TBL] [Abstract][Full Text] [Related]
33. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus.
Ueda T; Ohta K; Suzuki N; Yamaguchi M; Hirai K; Horiuchi T; Watanabe J; Miyamoto T; Ito K
Am Rev Respir Dis; 1992 Jul; 146(1):266-8. PubMed ID: 1320820
[TBL] [Abstract][Full Text] [Related]
34. [Anti-GOR antibodies in type II mixed cryoglobulinemia associated with hepatitis C virus infection].
Ballarè M; Quaglia V; Di Natale C; Zaccala G; Catania E; Fortina G; Monteverde A
Ann Ital Med Int; 1995; 10(2):98-101. PubMed ID: 7619658
[TBL] [Abstract][Full Text] [Related]
35. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
Pereira FM; Zarife MA; Reis EA; G Reis M
Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
[TBL] [Abstract][Full Text] [Related]
36. Early antihepatitis C virus response with second-generation C200/C22 ELISA.
van der Poel CL; Bresters D; Reesink HW; Plaisier AA; Schaasberg W; Leentvaar-Kuypers A; Choo QL; Quan S; Polito A; Houghton M
Vox Sang; 1992; 62(4):208-12. PubMed ID: 1322611
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
[TBL] [Abstract][Full Text] [Related]
38. [The prevalence of hepatitis C virus markers in a series of 14 patients with essential mixed cryoglobulinemia].
Yebra Bango M; Berrocal Valencia E; Vargas Núñez JA; Gea Banacloche JC; Ruiz Ruiz J; Romero Pizarro Y; Blanco Jiménez J; Diego Marín FJ; Durántez Martínez A
Rev Clin Esp; 1994 Jun; 194(6):472-6. PubMed ID: 8079017
[TBL] [Abstract][Full Text] [Related]
39. A role for hepatitis C virus infection in type II cryoglobulinemia.
Agnello V; Chung RT; Kaplan LM
N Engl J Med; 1992 Nov; 327(21):1490-5. PubMed ID: 1383822
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: a follow-up study.
Goeser T; Müller HM; Solbach C; Gmelin K; Kurzen F; Kommerell B; Theilmann L
Presse Med; 1994 Apr 30-May 7; 23(17):793-6. PubMed ID: 8078836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
